MedTrace Logo

Pathogenetic Mechanisms of Chronic Obstructive Pulmonary Diseases

NCT01378039 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2012-04-12

No results posted yet for this study

Summary

Asthma and chronic obstructive pulmonary disease(COPD) are common diseases, which tend to even increase in many countries. Both from a clinical and a pathophysiological point of view, this is an important issue. However, an understanding of the relationship between the complex array of cells and mediators involved in asthma and COPD is not yet fully dissected which makes difficult to find a specific and sensitive panel of biomarkers that can reflect intensity of these pathological processes and can help to predict the individual outcome.

Conditions

Interventions

DRUG

comparison of treatment effect on different markers

inhaled budesonide (400 µg BD) or placebo BD

Sponsors & Collaborators

  • Göteborg University

    collaborator OTHER

  • Lithuanian University of Health Sciences

    lead OTHER

Principal Investigators

  • Raimundas Sakalauskas, Prof. · Kaunas University of Medicine

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2006-12-31
Completion
2009-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01378039 on ClinicalTrials.gov